Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 07, 2017
Source ID
10.1371/journal.pone.0182683

Entities

People

  • Brian K. Martin
  • Carol B. Martin
  • Charles J. Link
  • Emily J. Dasen
  • Jinjin Zhang
  • Katie M. Hall
  • Nicholas N. Vahanian
  • Serguei Kisselev
  • Wenlan Alex Chen

Organizations

  • Defense Threat Reduction Agency

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech